Antithrombotic therapy

The European Society of Cardiology ( ESC ) has recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device...


Controversy persists over statins and risk of intracerebral hemorrhage. Researchers have determined associations of premorbid lipid-lowering therapy and outcomes among...


The results from two analyses of the GLORIA-AF Registry Program examining the use of antithrombotic treatment to reduce the risk...


Even a single additional stroke risk factor in patients with atrial fibrillation may confer a risk of stroke. However, there...


ESC Guidelines recommended for the radial approach over the femoral one for coronary angiography and percutaneous coronary intervention ( PCI...


Venous and arterial thromboses have been regarded for many years as two different diseases requiring anticoagulant or antiplatelet treatment, respectively....


Final data from a phase 2 comparator-controlled study evaluating the incidence of venous thromboembolic events ( VTE ) in patients...


Women suffer more disabling strokes than men and need to become better aware of their unique risk factors, according to...


For patients with atrial fibrillation or atrial flutter of 48-hour duration or longer, or when the duration of atrial fibrillation...


Anticoagulation may improve survival in patients with cancer through an antitumor effect in addition to the perceived antithrombotic effect. The purpose...


The options for secondary prevention of cryptogenic embolism in patients with patent foramen ovale are administration of antithrombotic medications or...


The WOEST ( What is the Optimal Antiplatelet and Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary Stenting )...


Anticoagulation - For patients with active cancer, low-molecular-weight Heparin monotherapy without the transition to oral anticoagulation is preferred over Warfarin...


The risk of stroke varies considerably across different groups of patients with atrial fibrillation. Antithrombotic prophylaxis for stroke is associated...


In patients with myocardial infarction, risk of hospital admission for bleeding increases with the number of antithrombotic drugs used. Patients...


The FDA ( Food and Drug Administration ) has completed a safety review of Multaq ( Dronedarone ). This review...


Clinical trials are needed to assess the clinical benefit of antithrombotic prophylaxis in patients with cancer who are receiving chemotherapy,...


In myocardial infarction patients, risk of hospital admission for bleeding increases with the number of antithrombotic drugs used. Patients with...


Clinical trials comparing antithrombotic therapy with placebo have shown that Warfarin ( Coumadin ) reduces the risk of stroke by...


A prospective observational analysis, coordinated by the DCRI ( Duke Clinical Research Institute ), in 387 US hospitals of...